Vaccines Related News
The medical cold chain and sustainable health systems
Industry pioneer of the medical and vaccine cold chain sectors, B Medical Systems, explores the challenges of achieving sustainability for the future of our...
Defence Therapeutics: changing the face of vaccines using AccumTM technology
Biotechnology specialists Defence Therapeutics are changing the face of vaccines using its AccumTM technology to enable precise delivery of proteins of pharmacological interest to...
Risk of COVID-19 infection steadily increases after second vaccine dose
A research team based in Israel has identified that the risk of infection from COVID-19 gradually increases after receiving a second vaccine dose.
Research emerging...
Combatting Crimean-Congo haemorrhagic fever with COVID technology
A scientific research consortium called Prometheus is employing the same framework used to develop COVID-19 vaccines to tackle Crimean-Congo haemorrhagic fever.
Crimean-Congo haemorrhagic fever (CCHF)...
New research into Alzheimer’s treatment and potential vaccine
A promising new approach to Alzheimer’s treatment and vaccinating against it has been developed by a team of UK and German scientists.
The research published...
Investigating the impacts of COVID-19 variants on dialysis treatment
A team of international researchers has examined the efficacy of COVID-19 vaccines for patients undergoing dialysis treatment.
The study, led by experts at the Marien...
Ebola vaccine by University of Oxford to begin human trials
The University of Oxford has begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers against Zaire and Sudan...
Vaccines to be compulsory for frontline NHS staff in England
The Health and Social Care Secretary, Sajid Javid, has announced that NHS staff will be required to be fully vaccinated against COVID-19 unless they...
Defence Therapeutics: Optimising drug efficacy with AccumTM technology
Health Europa is excited to introduce the latest captivating eBook from industry pioneers of the biotechnology sector, Defence Therapeutics, who comprehensively elucidate their revolutionary...
Defence Therapeutics successfully test new COVID vaccine
Defence Therapeutics has sensationally revealed that they have successfully completed studies of their new COVID vaccine in a non-rodent rabbit model.
The innovative new COVID...
Pfizer/BioNTech booster vaccine reduces COVID-19 hospitalisations
In the most extensive real-world study to date, an international research team has identified that the Pfizer/BioNTech booster vaccine is highly effective at reducing...
Health Europa Quarterly Issue 19
Welcome to Health Europa Quarterly Issue 19, which comprehensively investigates the current health landscape, from combatting COVID-19 and tackling healthcare inequalities to women’s health...
Uncovering why the COVID-19 Delta Variant is exceptionally infectious
Research emerging from the United States has revealed what makes the dreaded COVID-19 Delta Variant so infectious, a breakthrough that may help to design...
COVID-19 antibodies significantly boosted in double vaccinated individuals
A study conducted in Sweden has elucidated that although COVID-19 antibodies are reduced in the airways following SARS-CoV-2 infection, two vaccine doses increase these...
Medical professionals urge the public to get the influenza vaccine
A plethora of critical care and pulmonary societies are advising the public to receive the influenza vaccine as we edge closer to the flu...
WHO: Distribution crucial to malaria vaccine success
In an exciting development for modern medicine, the World Health Organization (WHO) announced last week that it recommends the rollout of the world's first...
Vaccine hesitancy: Protecting pregnant women against COVID-19
Dr Patrick O’Brien, Vice President of the Royal College of Obstetricians and Gynaecologists, discusses vaccine hesitancy among pregnant women.
On average, it takes a decade...
Defence Therapeutics prepares to test its DC cancer vaccine against melanoma
Defence Therapeutics is finalising all required steps in preparation for a pre-IND meeting to initiate a phase I trial against melanoma using its DC cancer...
Vaccine cold chain pioneers inaugurate new factory extension
Luxemburg-based vaccine cold chain specialists B Medical Systems have conducted the opening ceremony of their cutting-edge factory extension at its corporate headquarters.
The factory extension...
Pfizer COVID vaccine demonstrates excellent efficacy against all variants
A novel study has revealed that two doses of the Pfizer COVID vaccine achieve 90% effectiveness against hospitalisations for at least six months against...